The Latest Cancer Drugs News
Browsing: Cancer Drug News
Acalabrutinib demonstrated superior progression-free survival for r/r chronic lymphocytic leukaemia patients
Acalabrutinib, a next-generation selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in the European…
Acalabrutinib demonstrated superior progression-free survival for r/r chronic lymphocytic leukaemia patients
Acalabrutinib, a next-generation selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in the European…
Acalabrutinib demonstrated superior progression-free survival for r/r chronic lymphocytic leukaemia patients
Acalabrutinib, a next-generation selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in the European…
Acalabrutinib demonstrated superior progression-free survival for r/r chronic lymphocytic leukaemia patients
Acalabrutinib, a next-generation selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in the European…
FDA approves liquid biopsy NGS companion diagnostic test for multiple cancers and biomarkers
On October 26 and November 6, 2020, the Food and Drug Administration approved the liquid…
Prostate cancer drug targeting Achilles heel approved in Europe
The Institute of Cancer Research, London, UK, has strongly welcomed the approval by the European…
Prostate cancer drug targeting Achilles heel approved in Europe
The Institute of Cancer Research, London, UK, has strongly welcomed the approval by the European…
NCRI 2020: New bowel cancer model uncovering how it avoids immunotherapy drug
Scientists at The Institute of Cancer Research, London, UK, have developed a complex model system…
ICR welcomes NICE’s decision to reassess abiraterone as first-line treatment for advanced prostate cancer
The Institute of Cancer Research, London, UK, has welcomed the announcement by NICE that it…
BMS Announces EU approval of first-line treatment option for advanced non-small cell lung cancer
Bristol Myers Squibb (NYSE: BMY) announced that the European Commission (EC) has approved Opdivo (nivolumab)…